And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We hope to catch up on some naps and our reading, hang with our short people, and stroll with our official mascot. And what about you? With a long, holiday weekend on this side of the pond, you could take time to binge watch a favorite show or curl up with a good book. You could also make time for someone special. Or place bets on when the U.S. government will re-open for business. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you on Tuesday …

The Food and Drug Administration plans to furlough more people and suspend lower-priority tasks to preserve money for drug reviews, including for new treatments for depression, diabetes, and several types of cancer, The Washington Post says. With money for drug reviews rapidly diminishing as the government shutdown drags into its fourth week, FDA Commissioner Scott Gottlieb says that he plans to curtail “discretionary activities” and call for additional furloughs in areas in which workloads have been reduced due to the shutdown.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy